• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Cognitive Function may be Affected in Adults With Sickle Cell Disease, Study Suggests

Adults with sickle cell disease score worse than their healthy, unaffected siblings on cognitive tests, despite treatment with hydroxyurea, a study reports.

The study “Neurocognitive functioning in symptomatic adults with sickle cell disease: A description and comparison with unaffected siblings” was published in the journal Neuropsychological Rehabilitation.

Children and adults with sickle cell disease (SCD) often experience a shortage in blood supply, and strokes, that can severely affect their brain and lead to neurological impairments. Researchers believe the long-term consequences of these deficits in childhood are likely to have an impact on patients’ lives as adults. But neurocognitive functioning in adults with sickle cell disease remains poorly investigated.

To learn more, researchers evaluated specific cognitive parameters in symptomatic adults with SCD and compared the outcomes to their healthy siblings.



To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.